Last quarter (Q4 2023), Cellebrite DI's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Cellebrite DI's net income was $―. See Cellebrite DI’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 134.25M	$ 304.87M	$ 270.65M	$ 246.25M	$ 194.91M
Cost of Revenue	$ 27.63M	$ 32.99M	$ -50.75M	$ -42.56M	$ 37.88M
Gross Profit	$ 106.62M	$ 271.88M	$ 219.91M	$ 203.69M	$ 157.03M
Operating Expense	$ 113.30M	$ 238.88M	$ -218.86M	$ -189.87M	$ 147.82M
Operating Income	$ -6.68M	$ 33.00M	$ 1.04M	$ 13.82M	$ 9.22M
Net Non Operating Interest Income Expense	$ 63.89M	$ 10.57M	$ 119.72M	$ 68.48M	$ 2.63M
Other Income Expense	-	$ 119.35M	$ -116.86M	$ -197.82M	$ -446.00K
Pretax Income	$ 57.20M	$ -75.56M	$ 120.76M	$ 82.31M	$ 11.40M
Tax Provision	$ -1.08M	$ 5.54M	$ -45.00K	$ 10.91M	$ 5.62M
Earnings From Equity Interest Net Of Tax	-	-	-	$ 100.00M	-
Net Income Common Stockholders	$ 58.29M	$ -81.10M	$ 236.92M	$ 141.83M	$ -9.34M
Basic EPS	$ 0.31	$ -0.43	$ 0.64	$ 0.49	$ -0.05
Diluted EPS	$ 0.30	$ -0.43	$ 0.59	$ 0.44	$ -0.05
Basic Average Shares	$ 365.18M	$ 190.15M	$ 182.69M	$ 144.00M	$ 187.17M
Diluted Average Shares	$ 385.32M	$ 190.15M	$ 195.39M	$ 161.54M	$ 187.17M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	$ 0.02	-	-	-	-
Reported Normalized Diluted E P S	$ <0.01	-	-	-	-
Rent Expense Supplemental	-	-	-	-	$ 2.15M
Total Expenses	$ 140.93M	$ 271.87M	$ -269.61M	$ -232.42M	$ 185.69M
Net Income From Continuing And Discontinued Operation	$ 58.29M	$ -81.10M	$ 120.81M	$ 71.40M	$ 5.78M
Normalized Income	$ 58.29M	-	-	-	$ 6.12M
Interest Expense	-	-	-	-	-
EBIT	$ -6.68M	-	$ 120.76M	$ 13.82M	$ 9.22M
EBITDA	$ -2.12M	-	$ 129.95M	$ 20.83M	$ 15.10M

Currency in USD

Cellebrite DI Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing